Active Pharmaceutical Ingredients (API) Production
Grindeks has been at the forefront of API manufacturing for over three decades. We provide a diverse range of services including the supply of APIs, long-term manufacturing contracts for intermediates, and the development of new APIs tailored to specific requirements. Our commitment to delivering value-added services cost-effectively has made us a trusted partner for global pharmaceutical companies. Renowned clients like Teva Pharmaceuticals, Jubilant, Glenmark, and others regularly source their APIs from us, benefiting from our consistent track record of excellence.

Biotechnology
Since 2007, Grindeks has recognized the critical role of biotechnology in advancing the pharmaceutical industry, focusing on the specificity and effectiveness of drug therapies. Our biotech drug discovery R&D, developed in collaboration with an Israeli partner, is pioneering in the field of Recombinant fusion proteins for treating asthma and Mastocytosis. Our ongoing research aims to create groundbreaking treatments that address unmet medical needs, with ongoing projects in preclinical stages including toxicology and animal studies.

Animal Health
Grindeks has expanded its expertise to the veterinary sector, offering a comprehensive range of finished products for animal health since 1997. Our commitment to quality and innovation continues to drive our efforts in this area, ensuring effective solutions for veterinary care.

Corporate Milestones and Achievements:

• Established in 1982, consistently profitable since inception.
• In 2007, awarded a Gold Medal by Lockheed Martin for biotech innovation.
• Recognized R&D unit by DSIR since 2008.
• Launched a new manufacturing plant in 2010 with US FDA approbation.
• Achieved WHO GMP certification for API manufacturing in 2012.
• Consistently rated ‘A1’ by Dun and Bradstreet and awarded multiple times for business excellence and ethical practices.

Grindeks is dedicated to excellence in manufacturing, research, and client service, adhering to the highest international standards across all operations. We continue to innovate within the industry, driven by a commitment to improving health outcomes globally. For partnerships, research collaborations, or more information about our capabilities, please contact us directly.